Jordan vs Puerto Rico: Treatment success rate for patients treated for MDR-TB
Jordan
100.0%
in 2022
Puerto Rico
100.0%
in 2020
Jordan rank
1st
Puerto Rico rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Jordan
- Puerto Rico
How they compare
Jordan currently reports 100.0% against 100.0% in Puerto Rico, a difference of 0.0%.
The two have swapped places 3 times across 9 shared years of data; in 2006 it was Jordan ahead.
Jordan ranks 1st and Puerto Rico ranks 1st of 163 countries.
Across the 3 decades both report, Jordan averaged higher in 1 and Puerto Rico in 1.
Head to head by decade
| Decade | Jordan | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.0% | 33.3% | 26.7% | Jordan |
| 2010s | 67.4% | 73.4% | 6.0% | Puerto Rico |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Jordan or Puerto Rico?
- Jordan, at 100.0% against 100.0% in Puerto Rico as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Jordan and Puerto Rico?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Puerto Rico?
- 9 years are reported by both, from 2006 to 2020.
- How do Jordan and Puerto Rico rank globally for treatment success rate for patients treated for mdr-tb?
- Jordan ranks 1st and Puerto Rico ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.